<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4702">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01688102</url>
  </required_header>
  <id_info>
    <org_study_id>MPO-0787</org_study_id>
    <nct_id>NCT01688102</nct_id>
  </id_info>
  <brief_title>The Effect of Oral Vitamin D Versus Narrow-Band UV-B Exposure on the Lipid Profile</brief_title>
  <official_title>The Effect of Oral Vitamin D Versus Narrow-Band UV-B Exposure on the Lipid Profile</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rockefeller University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rockefeller University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Participants in this study will be randomized to receive either oral vitamin D pills OR
      ultraviolet light treatment.  The investigators will compare how these two methods of
      raising vitamin D levels will affect cholesterol levels.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2012</start_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in LDL Cholesterol Level</measure>
    <time_frame>baseline and 6 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Total Cholesterol</measure>
    <time_frame>baseline and 6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in HDL Cholesterol</measure>
    <time_frame>baseline and 6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in triglycerides</measure>
    <time_frame>baseline 6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in hs-CRP</measure>
    <time_frame>baseline and 6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Correlation between change in LDL cholesterol and change in calcium</measure>
    <time_frame>2 months and 6 months</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Correlation between change in LDL cholesterol and change in PTH</measure>
    <time_frame>2 months and 6 months</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Cholesterol</condition>
  <arm_group>
    <arm_group_label>Oral Vitamin D3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive oral vitamin D3 50,000 units weekly for 8 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ultraviolet Light</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will receive 16 treatments with ultraviolet light (narrow band UVB)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Oral Vitamin D3</intervention_name>
    <arm_group_label>Oral Vitamin D3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Ultraviolet Light</intervention_name>
    <arm_group_label>Ultraviolet Light</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age &gt; 18 years

          2. Vitamin D 25-OH level &lt; 20 ng/ml

        Exclusion Criteria:

          1. Serum calcium &gt; 10.5 mg/dl

          2. Serum phosphorus &gt; 5.5 mg/dl

          3. Serum PTH level &lt; 12 pg/ml

          4. LDL cholesterol &gt; 190 mg/dl

          5. History of recent acute infection (within 1 month)

          6. Glomerular filtration rate(GFR) &lt; 60 mL/min

          7. Liver Function tests indicative of liver disease (AST or ALT &gt; 3x ULN)

          8. Current use of Vitamin D &gt; 400 IU/day

          9. Current use of any statins, fibrates, niacin, or ezetimibe

         10. Current use of any medications affecting sensitivity to UV light

         11. Pregnancy (self-reported)

         12. Intentional UV exposure (e.g. tanning bed use) in the last 2 weeks or planned use
             while participating in the study

         13. history of malignancy not in remission (&gt; 6 months)

         14. History of malignant melanoma

         15. Participation in an investigational drug study within 30 days of the screening visit

         16. Any medical, psychological or social condition that, in the opinion of the
             Investigator, would jeopardize the health or well-being of the participant during any
             study procedures or the integrity of the data.

         17. History of any non-melanoma skin cancer
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manish Ponda, MD MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Rockefeller University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Manish Ponda, MD MS</last_name>
    <phone>212-327-7631</phone>
  </overall_contact>
  <location>
    <facility>
      <name>The Rockefeller University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>RU Cares</last_name>
      <phone>800-782-2737</phone>
    </contact>
    <investigator>
      <last_name>Manish Ponda, MD MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 14, 2013</lastchanged_date>
  <firstreceived_date>September 12, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rockefeller University</investigator_affiliation>
    <investigator_full_name>Manish Ponda</investigator_full_name>
    <investigator_title>Assistant Professor of Clinical Investigation</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
